Results 61 to 70 of about 1,171,517 (222)

NR-U and IEEE 802.11 Technologies Coexistence in Unlicensed mmWave Spectrum: Models and Evaluation

open access: yesIEEE Access, 2020
New Radio-based access to Unlicensed spectrum (NR-U) intends to expand the applicability of 5G NR access technology to support operation in unlicensed bands by adhering to Listen-Before-Talk (LBT) requirement for accessing the channel.
Natale Patriciello   +3 more
doaj   +1 more source

Ironic Medications: A Narrative‐Based Psycho‐Educational Intervention to Explore Patient–Provider Communication in Adolescents With Haematological Cancer

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Adolescents with haematological malignancies face significant emotional and relational challenges, often accompanied by difficulties in communicating their needs within the healthcare context. To address these issues, a narrative‐based psycho‐educational intervention based on the creation and prescription of Ironic Medications was ...
Marta Stoppa   +7 more
wiley   +1 more source

Coherent e+e- production at very low transverse momentum at STAR

open access: yesEPJ Web of Conferences, 2018
We report the measurements of e+e- pair production at very low e+e- pair transverse momentum (pT < 0.15 GeV/c) in Au+Au collisions at sNN = 200 GeV and U+U collisions at sNN = 193 GeV using the STAR detector at the Relativistic Heavy Ion Collider.
Yang Chi
doaj   +1 more source

Incidence and Severity of Carboplatin‐Associated Hearing Loss in Children With Cancer Assessed by the SIOP Boston 2012 Ototoxicity Criteria

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Platinum‐based chemotherapy is known to cause severe and debilitating hearing loss, but unlike cisplatin, the true incidence of carboplatin‐induced hearing loss remains unclear. We evaluated functional hearing outcomes in children receiving carboplatin to determine the incidence and severity of ototoxicity. Procedure We identified a
Aniket Chawla   +6 more
wiley   +1 more source

Re‐Irradiation in Pediatric Diffuse Midline Glioma: A Multi‐Institutional Retrospective Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Children with recurrent diffuse midline gliomas (DMGs) have limited therapeutic options at recurrence. Re‐irradiation (RT2) may be used at progression, but with uncertainty about the benefit. Methods We conducted a multi‐institutional retrospective study of children aged < 18 with DMG treated at three centers (Toronto, Canada ...
Ajay Thomas Alex   +13 more
wiley   +1 more source

The complete mitochondrial genome of Urocitellus undulatus and its phylogenetic analysis

open access: yesMitochondrial DNA. Part B. Resources
The long-tailed ground squirrel (Urocitellus undulatus) is primarily distributed in various regions, including Xinjiang and Heilongjiang in China, as well as in Siberia, Mongolia, the Russian Federation, and Kazakhstan.
Zimeng Liu   +10 more
doaj   +1 more source

Digest of U-Report surveys: 1st quarter of 2019 [PDF]

open access: yesUkrainian society, 2019
Yevheniia Nesterenko, Karyna Liudohovska
openaire   +1 more source

Long term follow-up (F/U) report of symptomatic cardiac events (SCEs) in 2,809 breast cancer (BC) patients (pts) treated with adjuvant trastuzumab (T) in real world (RW) practice

open access: yesAnnals of Oncology, 2019
Abstract Background Clinical trials, focusing on selected pts, may have underestimated toxicities in cases with advanced age and co-morbidities, that are common in RW practice. Furthermore, clinical trials do not provide extended F/U. Thus, we assessed acute and long-term SCEs after adjuvant T in a large/unselected BC pt population.
S. Di Cosimo   +7 more
openaire   +1 more source

Association Between Dinutuximab Beta Exposure and Post‐End‐of‐Treatment Survival in Neuroblastoma: A Weighted Patient‐Level Analysis of Three Clinical Studies

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Objectives The association between exposure to dinutuximab beta (DB) and event‐free survival (EFS) or overall survival (OS) of neuroblastoma patients was assessed using data collected during three clinical trials (five cohorts). Methods A systematic review (March 2026) was conducted to identify relevant studies (prospective; registered DB ...
Przemysław Holko   +19 more
wiley   +1 more source

Digest of U-Report surveys: 2nd quarter of 2018 [PDF]

open access: yesUkrainian society, 2018
Svitozar Nitspol, Yevheniia Nesterenko
openaire   +1 more source

Home - About - Disclaimer - Privacy